The arterial hypertension and kidney: The fateful duo of chronic non-communicable diseases
DOI:
https://doi.org/10.33064/iycuaa2020792961Keywords:
arterial hypertension, kidney, chronic kidney disease, chronic non-communicable diseasesAbstract
Chronic non-communicable diseases are leading cause of death worldwide. Among them, cardiovascular diseases are main cause of mortality and the main risk factor is hypertension, which is usually asymptomatic until the harmful effects are manifested. There is a strong relationship between hypertension and kidney, because on the one hand hypertension is the major risk factor for the initiation and progression of kidney disease and at the same time hypertension is the result of kidney disease itself. In this review, different aspects of arterial hypertension will be analyzed, such as its prevalence, classification, etiology, heritability and relationship with chronic noncommunicable diseases and the importance of the kidney in the regulation of blood pressure; as well as kidney disease and its relationship with hypertension and the deleterious consequences for health.
Downloads
Metrics
References
• Ahmeda, A. F., & Alzoghaibi, M. (2016). Factors regulating the renal circulation in spontaneously hypertensive rats.
Saudi Journal of Biological Sciences, 23(4), 441-451.
• Anari, R., Amani, R., Latifi, S. M., Veissi, M., & Shahbazian, H. (2017). Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects. Diabetes and Metabolic Syndrome, 11(1), 37-41.
• Barba Evia, J. R. (2018). México y el reto de las enfermedades crónicas no transmisibles. El laboratorio también juega un
papel importante. Revista Mexicana de Patología Clínica y Medicina de Laboratorio, 65(1), 4-17.
• Brenner, B. M., Garcia, D. L., & Anderson, S. (1988). Glomeruli and blood pressure. Less of one, more the other? American Journal of Hypertension, 1 (4Pt 1), 335-347.
• Britten, R. J., & Davidson, E. H. (1969). Gene regulation in higher cells. Science, 165(3891), 349-357. doi: 10.1126/science.165.3891.349
• Burton, M. A., & Lillycrop, K. A. (2019). Nutritional modulation of the epigenome and its implication for future health. The Proceedings of the Nutrition Society, 78(3), 305-312.
• Campos Nonato, I., Hernández-Barrera, L., Pedroza-Tobías, A., Medina, C., & Barquera, S. (2018). Hipertensión arterial
en adultos mexicanos: Prevalencia, diagnóstico y tipo de tratamiento. ENSANUT MC 2016. Salud Pública de México,
(3), 233-243.
• Curtis, J. J., Luke, R. G., Dustan, H. P., Kashgarian, M., Whelchel, J. D., Jones, P., & Diethelm, A. G. (1983). Remission of
essential hypertension after renal transplantation. The New England Journal of Medicine, 309(17), 1009-1015.
• De Taeye, B., Smith, L. H., & Vaughan, D. E. (2005). Plasminogen activator inhibitor-1: a common denominator in obesity,
diabetes and cardiovascular disease. Current Opinion in Pharmacology, 5(2), 149-154.
• Ettner, R., Ettner, F., & White, T. (2012). Secrecy and the pathogenesis of hypertension. International Journal of Family
Medicine, 2012, 492718.
• Feihl, F., Liaudet, L., Waeber, B., & Levy, B. I. (2006). Hypertension: A disease of the microcirculation? Hypertension, 48(6), 1012-1017.
• Gargiulo, R., Suhail, F., & Lerma, E. V. (2015). Hypertension and chronic kidney disease. Disease-a-month: DM, 61(9),
-395.
• Gekle, M. (2017). Kidney and aging - A narrative review. Experimental Gerontology, 87(Pt B), 153-155.
• Global Burden of Disease Study 2016 Risk Factors Collaborators. (2017). Global, regional, and national comparative risk
assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: A
systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1345-1422. doi: 10.1016/S0140-
(17)32366-8
• Gu, Q., Burt V. L., Paulose-Ram, R., Yoon, S., & Gillum, R. F. (2008). High blood pressure and cardiovascular disease
mortality risk among U.S. adults: The third National Health and Nutrition Examination Survey mortality follow-up study.
Annals of Epidemiology, 18(4), 302-309. doi: 10.1016/j.annepidem.2007.11.013
• Guyton, A. C., Coleman, T. G., Cowley, A. V., Scheel, K. W., Manning, R. D., & Norman, R. A. (1972). Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. The American Journal of
Medicine, 52(5), 584-594.
• Guyton, A. C., & Hall, J. E. (2007). Tratado de Fisiología Médica (7° ed.). México: Elsevier. • Hsu, C. N., & Tain, Y. L. (2019). Regulation of nitric oxide production in the developmental programming of hypertension and kidney disease. International Journal of Molecular Sciences, 20(3), pii: E681. doi: 10.3390/ijms20030681
• Kalaitzidis, R. G., & Bakris, G. L. (2010). Prehypertension: Is it relevant for nephrologists? Kidney International, 77(3), 194-200. doi: 10.1038/ki.2009.439
• Kapil, V., & Lobo, M. D. (2014). Hypertension. Medicine, 42(9), 485-490. doi: 10.1016/j.mpmed.2014.06.004
• Kasko, M., Budaj, M., & Hulin, I. (2012). Harmful or helpful hypertension-pathophysiological basis. En M. Khullar (Ed.),
Genetics and pathophysiology of essential hypertension (pp. 5-30). Croatia: InTech.
• Landmesser, U., & Drexler, H. (2007). Endothelial function and hypertension. Current Opinion in Cardiology, 22(4), 316-320.
• Mehta, P. K., & Griendling, K. K. (2007). Angiotensin II cell signaling: Physiological and pathological effects in the
cardiovascular system. American Journal of Physiology: Cell Physiology, 292(1), C82-C97.
• Méndez-Durán, A. J., Méndez-Bueno, J. F., Tapia-Yáñez, T, Muñoz-Montes, A., & Aguilar-Sánchez, L. (2010). Epidemiología de la insuficiencia renal crónica en México. Diálisis y Trasplante, 31(1), 7-11. doi: 10.1016/S1886-2845(10)70004-7
• Miller, A. J., & Arnold, A. C. (2018). The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research
Society, 29(2), 231-243. doi: 10.1007/s10286-018-0572-5
• Morgado, E., & Leão Neves, P. (2012). Hypertension and chronic kidney disease: Cause and consequence–therapeutic considerations. En H. Babaei (Ed.), Antihypertensive drugs (pp. 45-66). Croatia: InTech.
• Mulè, G., Castiglia, A., Cusumano, C., Scaduto, E., Geraci, G., Altieri, D.,… & Cottone, S. (2017). Subclinical kidney damage in hypertensive patients: A renal window opened on the cardiovascular system. Focus on Microalbuminuria.
Advances in Experimental Medicine and Biology, 956, 279-306. doi: 10.1007/5584_2016_85
• Munroe, P. B., Barnes, M. R., & Caulfield, M. J. (2013). Advances in blood pressure genomics. Circulation Research, 112(10), 1365-1379. doi: 10.1161/CIRCRESAHA.112.300387
• Pérez-Díaz, I., Hiriart, M., Olivares-Reyes, J. A., & Robles-Díaz, G. (2006). Receptores para la angiotensina II diferentes a los clásicos receptores membranales AT1 y AT2: Características y su papel en el funcionamiento celular. Revista de Educación Bioquímica, 25(2), 55-60.
• Perumareddi, P. (2019). Prevention of hypertension related to cardiovascular disease. Primary Care, 46(1), 27-39. doi:
1016/j.pop.2018.10.005
• Plavnik, F. L., Ajzen, S. A., Christofalo, D. M., Barbosa, C. S., & Kohlmann O. (2007). Endothelial function in normotensive
and high-normal hypertensive subjects. Journal of Human Hypertension, 21(6), 467-472. doi: 10.1038/sj.jhh.1002164
• Poulter, N. R., Prabhakaran, D., & Caulfield, M. (2015). Hypertension. The Lancet, 386(9995), P801-P812.
• Rettig, R., Folberth, C., Stauss, H., Kopf, D., Waldherr, R., & Unger, T. (1990). Role of the kidney in primary hypertension:
A renal transplantation study in rats. The American Journal of Physiology, 258(3 Pt 2), F606-F611. doi: 10.1152/ajprenal.1990.258.3.F606
• Schnaper, H. W. (2014). Remnant nephron physiology and the progression of chronic kidney disease. Pediatric Nephrology (Berlin, Germany), 29(2), 193-202. doi: 10.1007/s00467-013-2494-8
• Schrauben, S. J., Jepson, C., Hsu, J. Y., Wilson, F. P., Zhang, X., Lash, J. P.,… & Feldman, H. I. (2019). Insulin resistance and
chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency
cohort study. BMC Nephrology, 20(1), 60. doi: 10.1186/s12882-019-1220-6
• Secretaría de Salud. (2012). Resumen integrado Norma Oficial Mexicana NOM-030-SSA2-2009, para la prevención,
detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica. Revista Mexicana de Cardiología,
(Suplemento 1), 4A-38A. Recuperado de https://www.medigraphic.com/pdfs/cardio/h-2012/hs121a.pdf
• Velázquez, M. A., Fleming, T. P., & Watkins, A. J. (2019). Periconceptional environment and the developmental origins
of disease. The Journal of Endocrinology, 242(1), T33-T49. doi: 10.1530/JOE-18-0676
• Vío, C. P., & Jeanneret, V. A. (2003). Local induction of angiotensin-converting enzyme in the kidney as a mechanism
of progressive renal diseases. Kidney International. Supplement, 86, S57-S63.
• Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic kidney disease. The Lancet, 389(10075), 1238-1252. doi: 10.1016/S0140-6736(16)32064-5
• Weir, M. R. (2009). Hypertension and the kidney: Perspectives on the relationship of kidney disease and cardiovascular
disease. Clinical Journal of the American Society of Nephrology, 4(12), 2045-2050. doi: 10.2215/CJN.03050509
• Zehnder, C. (2005). Riñón e hipertensión. Revista Médica Clínica Condes, 16(2), 110-116. Recuperado de https://www.
clinicalascondes.cl/Dev_CLC/media/Imagenes/PDF%20revista%20m%C3%A9dica/2005/2%20abril/RinoneHipertension-13.pdf
Published
Versions
- 2020-01-31 (2)
- 2020-01-31 (1)
How to Cite
License
Copyright (c) 2020 Asdrúbal Aguilera-Méndez, Renato Nieto-Aguilar, Deyanira Serrato-Ochoa, Gema Cecilia Manuel-Jacobo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Las obras publicadas en versión electrónica de la revista están bajo la licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
